Targeting the Immunoproteasome in Health and Disease
S Mundt - 2016 - kops.uni-konstanz.de
The proteasome is a multicatalytic enzyme expressed in all eukaryotic cells and responsible
for the degradation of polyubiquitinated proteins. Thereby, the proteasome regulates protein …
for the degradation of polyubiquitinated proteins. Thereby, the proteasome regulates protein …
[PDF][PDF] The immunoproteasome: a novel drug target for autoimmune diseases
The immunoproteasome, a special class of the proteasome, is mainly expressed in cells of
haematopoietic origin. Additionally, during inflammation, the immunoproteasome is induced …
haematopoietic origin. Additionally, during inflammation, the immunoproteasome is induced …
[HTML][HTML] On the role of the immunoproteasome in protein homeostasis
M Basler, M Groettrup - Cells, 2021 - mdpi.com
Numerous cellular processes are controlled by the proteasome, a multicatalytic protease in
the cytosol and nucleus of all eukaryotic cells, through regulated protein degradation. The …
the cytosol and nucleus of all eukaryotic cells, through regulated protein degradation. The …
Immunoproteasome subunit LMP7 deficiency and inhibition suppresses Th1 and Th17 but enhances regulatory T cell differentiation
The immunoproteasome generates peptides presented on MHC class I molecules to
cytotoxic T cells. ONX 0914 (formerly called PR-957) is a selective inhibitor of the …
cytotoxic T cells. ONX 0914 (formerly called PR-957) is a selective inhibitor of the …
Targeting the immunoproteasome and VCP/p97 in autoimmune disorders and viral infection
M del Río Oliva - 2022 - kops.uni-konstanz.de
The proteasome is a multicatalytic system involved in the degradation of polyubiquitinated
proteins. Thus, the proteasome is key to maintaining cell homeostasis. Stress and pro …
proteins. Thus, the proteasome is key to maintaining cell homeostasis. Stress and pro …
The immunoproteasome: an emerging therapeutic target
The proteasome, a large multisubunit protease complex, has been extensively investigated
over the years, greatly enhancing our understanding of critical roles that the proteasome …
over the years, greatly enhancing our understanding of critical roles that the proteasome …
Amelioration of autoimmunity with an inhibitor selectively targeting all active centres of the immunoproteasome
Background and Purpose Multicatalytic endopeptidase complex‐like‐1 (β2i), low molecular
mass polypeptide (LMP) 2 (β1i) and LMP7 (β5i) are the proteolytically active subunits of the …
mass polypeptide (LMP) 2 (β1i) and LMP7 (β5i) are the proteolytically active subunits of the …
Abstract LB-054: Discovery and profiling of M3258, a potent and selective LMP7 inhibitor demonstrating high efficacy in multiple myeloma models
M Klein, M Busch, C Esdar, M Friese-Hamim, M Krier… - Cancer Research, 2019 - AACR
Proteasomes are large multi-subunit proteolytic complexes which are key components of the
ubiquitin-dependent protein degradation pathway. The constitutive proteasome is an isoform …
ubiquitin-dependent protein degradation pathway. The constitutive proteasome is an isoform …
Oxathiazolones selectively inhibit the human immunoproteasome over the constitutive proteasome
H Fan, NG Angelo, JD Warren… - ACS Medicinal …, 2014 - ACS Publications
Selective inhibitors for the human immunoproteasome LMP7 (β5i) subunit over the
constitutive proteasome hold promise for the treatment of autoimmune and inflammatory …
constitutive proteasome hold promise for the treatment of autoimmune and inflammatory …
Co‐inhibition of immunoproteasome subunits LMP2 and LMP7 is required to block autoimmunity
M Basler, MM Lindstrom, JJ LaStant, JM Bradshaw… - EMBO …, 2018 - embopress.org
Cells of hematopoietic origin express high levels of the immunoproteasome, a cytokine‐
inducible proteasome variant comprising the proteolytic subunits LMP2 (β1i), MECL‐1 (β2i) …
inducible proteasome variant comprising the proteolytic subunits LMP2 (β1i), MECL‐1 (β2i) …